Clinical Outcomes and Healthcare Resource Utilization of Ceftolozane/Tazobactam in Vulnerable Patient Populations.

Yücel E, Soriano A, Thalhammer F, Kluge S, Allen M, Levy J, Yang H, Kaul S

Open source

DOI
10.3390/antibiotics15020179
Published
2026 Feb 6
Container
Antibiotics (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/antibiotics15020179,
  title = {Clinical Outcomes and Healthcare Resource Utilization of Ceftolozane/Tazobactam in Vulnerable Patient Populations.},
  author = {Yücel E and Soriano A and Thalhammer F and Kluge S and Allen M and Levy J and Yang H and Kaul S},
  year = {2026},
  journal = {Antibiotics (Basel, Switzerland)},
  doi = {10.3390/antibiotics15020179},
  url = {https://doi.org/10.3390/antibiotics15020179}
}

RIS

TY  - JOUR
TI  - Clinical Outcomes and Healthcare Resource Utilization of Ceftolozane/Tazobactam in Vulnerable Patient Populations.
AU  - Yücel E
AU  - Soriano A
AU  - Thalhammer F
AU  - Kluge S
AU  - Allen M
AU  - Levy J
AU  - Yang H
AU  - Kaul S
PY  - 2026
JO  - Antibiotics (Basel, Switzerland)
DO  - 10.3390/antibiotics15020179
UR  - https://doi.org/10.3390/antibiotics15020179
ER  -

APA

E, Y., A, S., F, T., S, K., M, A., J, L., H, Y., & S, K. (2026). Clinical Outcomes and Healthcare Resource Utilization of Ceftolozane/Tazobactam in Vulnerable Patient Populations.. Antibiotics (Basel, Switzerland). https://doi.org/10.3390/antibiotics15020179

Source records